1. Home
  2. ALEC vs BHST Comparison

ALEC vs BHST Comparison

Compare ALEC & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.45

Market Cap

133.2M

Sector

Health Care

ML Signal

HOLD

Logo BioHarvest Sciences Inc. Common Stock

BHST

BioHarvest Sciences Inc. Common Stock

HOLD

Current Price

$5.63

Market Cap

137.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALEC
BHST
Founded
2013
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.2M
137.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ALEC
BHST
Price
$1.45
$5.63
Analyst Decision
Hold
Strong Buy
Analyst Count
8
2
Target Price
$3.50
$13.00
AVG Volume (30 Days)
1.7M
74.3K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,048,000.00
$32,720,000.00
Revenue This Year
N/A
$116.40
Revenue Next Year
$160.66
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
12.26
45.88
52 Week Low
$0.87
$4.72
52 Week High
$3.40
$12.80

Technical Indicators

Market Signals
Indicator
ALEC
BHST
Relative Strength Index (RSI) 52.71 35.11
Support Level $1.18 $6.12
Resistance Level $1.39 $6.89
Average True Range (ATR) 0.10 0.55
MACD 0.06 0.05
Stochastic Oscillator 82.22 20.99

Price Performance

Historical Comparison
ALEC
BHST

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: